Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -713,410 | 235,239 | -535,977 | -703,488 | -418,780 |
| Depreciation Amortization | 39,230 | -2,553 | -1,779 | 31,213 | 37,915 |
| Accounts receivable | 203,755 | -201,661 | -185,699 | -61,638 | -51,650 |
| Other Working Capital | 78,038 | -716,606 | -481,089 | -39,470 | -98,166 |
| Other Operating Activity | 186,908 | 479,794 | 703,551 | 448,037 | 87,509 |
| Operating Cash Flow | $-205,479 | $-205,787 | $-500,993 | $-325,346 | $-443,172 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 251,213 | 902,517 | -176,458 | N/A | 436,012 |
| PPE Investments | -101,972 | -136,956 | -76,106 | -30,824 | -38,490 |
| Purchase Of Investment | -245,819 | N/A | -4,000 | -1,937,856 | -1,800 |
| Sale Of Investment | 174,095 | N/A | N/A | 923,224 | N/A |
| Purchase Sale Intangibles | -7,876 | -10,000 | 90,761 | -1,427 | 99,691 |
| Other Investing Activity | -7,876 | -10,000 | 90,761 | -1,427 | 99,691 |
| Investing Cash Flow | $69,641 | $755,561 | $-165,803 | $-1,046,883 | $495,413 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,127,400 | N/A |
| Debt Repayment | -162,588 | -68 | N/A | -823,232 | N/A |
| Common Stock Issued | 38,703 | 79,525 | 51,246 | 30,043 | 569,334 |
| Common Stock Repurchased | -25,013 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -19,446 | 45,349 | 73,758 | -101,704 | -7,765 |
| Financing Cash Flow | $-168,344 | $124,806 | $125,004 | $232,507 | $561,569 |
| Beginning Cash Position | 1,118,589 | 444,009 | 985,801 | 2,125,523 | 1,511,713 |
| End Cash Position | 814,407 | 1,118,589 | 444,009 | 985,801 | 2,125,523 |
| Net Cash Flow | $-304,182 | $674,580 | $-541,792 | $-1,139,722 | $613,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205,479 | -205,787 | -500,993 | -325,346 | -443,172 |
| Capital Expenditure | -101,972 | -136,956 | -76,106 | -30,824 | -38,490 |
| Free Cash Flow | -307,451 | -342,743 | -577,099 | -356,170 | -481,662 |